I recently provided insight for a Modern Healthcare article that examines the Department of Justice’s (DOJ) increased healthcare fraud enforcement efforts and growing use of artificial intelligence (AI) and data analytics in civil investigations. While whistleblower complaints continue to account for a substantial share of False Claims Act recoveries, the article highlights how enforcement agencies are increasingly using technology to identify billing outliers and support government-initiated investigations.

Continue Reading DOJ’s Expanding Healthcare Fraud Enforcement Efforts

I recently participated in a panel discussion at the Federal Bar Association’s 2026 Qui Tam Conference focused on “‘Illegal DEI’ as an FCA Trigger.” We explored the scope of False Claims Act (FCA) enforcement under the Department of Justice’s (DOJ) Civil Rights Fraud Initiative and recent executive actions addressing “illegal DEI [diversity, equity and inclusion].” In addition to law firm attorneys, our panel included a speaker from the DOJ.

Continue Reading Insight on “Illegal DEI” as FCA Trigger at Federal Bar Association’s Qui Tam Conference

Bass, Berry & Sims released its 14th Annual Healthcare Fraud & Abuse Review in mid-February. As a companion to the Review, hosted a complimentary webinar, which provided an overview and discussion of key focus areas covered in the Review.

Continue Reading Watch Now | Healthcare Fraud & Abuse Annual Review Webinar

The federal government’s growing use of the False Claims Act (FCA) to pursue customs fraud signals a new era of trade enforcement, with importers facing heightened scrutiny and increased risk of whistleblower actions.

Continue Reading Cracking Down on Customs Fraud: How the False Claims Act Raises the Stakes for Importers

Effective wound care is critical for patients recovering from surgery or managing chronic or non-healing wounds. Advances in treatment have led to the development of skin substitutes—bioengineered or natural materials designed to promote healing by replacing or supporting damaged skin. While these innovations hold great promise for the future of wound care, they have also come under increased scrutiny by regulatory agencies and the Department of Justice (DOJ).

Continue Reading Wound Care in the Crosshairs: Reimbursements Risks Amid Skin Substitute Fraud Investigations

I recently authored an article for the American Bar Association (ABA) Health Law Section regarding healthcare fraud enforcement trends in 2024 and the projected issues for 2025, which highlights the Department of Justice’s (DOJ) increasing focus on fraud, waste, and abuse.

Continue Reading Healthcare Fraud Enforcement Trends from 2024 and Projected Issues for 2025